| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |